{"id":"https://openalex.org/W2162578613","doi":"https://doi.org/10.1177/1087057112444927","title":"Potential Repurposing of Known Drugs as Potent Bacterial \u03b2-Glucuronidase Inhibitors","display_name":"Potential Repurposing of Known Drugs as Potent Bacterial \u03b2-Glucuronidase Inhibitors","alternate_titles":[],"publication_year":2012,"publication_date":"2012-04-25","ids":{"openalex":"https://openalex.org/W2162578613","doi":"https://doi.org/10.1177/1087057112444927","mag":"2162578613","pmid":"https://pubmed.ncbi.nlm.nih.gov/22535688","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8284931"},"language":"en","primary_location":{"id":"doi:10.1177/1087057112444927","doi":"https://doi.org/10.1177/1087057112444927","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057112444927","pdf_url":null,"source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2162578613"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1177/1087057112444927","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078773370","display_name":"Syed Sayeed Ahmad","orcid":"https://orcid.org/0000-0002-2829-2768","observed_orcids":["https://orcid.org/0000-0002-2829-2768"]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Syed Ahmad","raw_affiliation_strings":["Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark A. Hughes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark A. Hughes","raw_affiliation_strings":["Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112868313","display_name":"Li-An Yeh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Li-An Yeh","raw_affiliation_strings":["Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"last","author":{"id":null,"display_name":"John E. Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John E. Scott","raw_affiliation_strings":["Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, NC, USA","institution_ids":["https://openalex.org/I123127086"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I123127086"],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":{"value":2070,"currency":"USD","value_usd":2070},"fwci":1.2503,"has_fulltext":false,"cited_by_count":50,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.7252534,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"17","issue":"7","first_page":"957","last_page":"965"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7157999873161316,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7157999873161316,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.07670000195503235,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.07199999690055847,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.9700000286102295},{"id":"https://openalex.org/keywords/beta-glucuronidase-inhibition","display_name":"\u03b2-glucuronidase inhibition","score":0.8619999885559082},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.8980000019073486},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.9160000085830688},{"id":"https://openalex.org/keywords/glucuronidation","display_name":"glucuronidation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/nialamide","display_name":"nialamide","score":0.8289999961853027},{"id":"https://openalex.org/keywords/isocarboxazid","display_name":"isocarboxazid","score":1.0},{"id":"https://openalex.org/keywords/phenelzine","display_name":"phenelzine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/amoxapine","display_name":"amoxapine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/mefloquine","display_name":"mefloquine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibitors","display_name":"monoamine oxidase inhibitors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.9210000038146973},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.8679999709129333},{"id":"https://openalex.org/keywords/drug-screening","display_name":"drug screening","score":0.3490000069141388}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6952325701713562},{"id":"https://openalex.org/C2775905453","wikidata":"https://www.wikidata.org/wiki/Q2359711","display_name":"Nialamide","level":2,"score":0.540560781955719},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5129384994506836},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.44012707471847534},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.43953096866607666},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.4383479654788971},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.43264126777648926},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31789034605026245},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.27294111251831055},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2631816267967224},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10095122456550598}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000657","descriptor_name":"Amoxapine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005966","descriptor_name":"Glucuronidase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D007520","descriptor_name":"Isocarboxazid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009526","descriptor_name":"Nialamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010624","descriptor_name":"Phenelzine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015767","descriptor_name":"Mefloquine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D029968","descriptor_name":"Escherichia coli Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/1087057112444927","doi":"https://doi.org/10.1177/1087057112444927","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057112444927","pdf_url":null,"source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},{"id":"pmid:22535688","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22535688","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biomolecular screening","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8284931","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8284931/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Biomol Screen","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1177/1087057112444927","doi":"https://doi.org/10.1177/1087057112444927","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057112444927","pdf_url":null,"source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8680875447","display_name":"Discovery of a Selective Agent that Activates PON1 Enzymatic Activity","funder_award_id":"SC2GM081129","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1593902116","https://openalex.org/W1777256341","https://openalex.org/W1966336229","https://openalex.org/W1978838773","https://openalex.org/W2025080629","https://openalex.org/W2030936467","https://openalex.org/W2033992383","https://openalex.org/W2040331658","https://openalex.org/W2043574482","https://openalex.org/W2046850261","https://openalex.org/W2055175246","https://openalex.org/W2074951050","https://openalex.org/W2080856125","https://openalex.org/W2085701551","https://openalex.org/W2089458297","https://openalex.org/W2095125338","https://openalex.org/W2113770459","https://openalex.org/W2121666688","https://openalex.org/W2122206675","https://openalex.org/W2125060052","https://openalex.org/W2127287358","https://openalex.org/W2139184213","https://openalex.org/W2140145798","https://openalex.org/W2146274229","https://openalex.org/W2146917615","https://openalex.org/W2153320441","https://openalex.org/W2159266419","https://openalex.org/W2414951513","https://openalex.org/W2988126625","https://openalex.org/W4243955582"],"related_works":["https://openalex.org/W3135904459","https://openalex.org/W2097468619","https://openalex.org/W2996043414","https://openalex.org/W3006712416","https://openalex.org/W7163703398","https://openalex.org/W7170170610","https://openalex.org/W2046850261","https://openalex.org/W4403270120","https://openalex.org/W3146629563"],"abstract_inverted_index":{"The":[0,119],"active":[1],"metabolite":[2,24],"of":[3,45,66,94,112,172],"the":[4,16,22,27,97,128],"chemotherapeutic":[5],"irinotecan,":[6],"SN-38,":[7],"is":[8],"detoxified":[9],"through":[10],"glucuronidation":[11],"and":[12,68,103,115,127,140,175,182,198],"then":[13],"excreted":[14],"into":[15],"gastrointestinal":[17],"tract.":[18],"Intestinal":[19],"bacteria":[20],"convert":[21],"glucuronidated":[23],"back":[25],"to":[26,52,88,186,191],"toxic":[28],"SN-38":[29],"using":[30,78,163],"\u03b2-glucuronidase":[31],"(GUS),":[32],"resulting":[33],"in":[34,159],"debilitating":[35],"diarrhea.":[36],"Inhibiting":[37],"GUS":[38,59,111,149,157],"activity":[39,145,153,158],"may":[40],"relieve":[41],"this":[42,48,203],"side":[43],"effect":[44],"irinotecan.":[46],"In":[47],"study,":[49],"we":[50],"sought":[51],"determine":[53],"whether":[54],"any":[55],"known":[56],"drugs":[57,71,85],"have":[58,184],"inhibitory":[60],"activity.":[61,137],"We":[62],"screened":[63],"a":[64,73,160],"library":[65],"Food":[67],"Drug":[69],"Administration-approved":[70],"with":[72,105,168,195],"cell-free":[74],"biochemical":[75],"enzyme":[76],"assay":[77,162],"purified":[79,90,147],"bacterial":[80,91],"GUS.":[81,92],"After":[82],"triage,":[83],"five":[84],"were":[86,96],"confirmed":[87],"inhibit":[89],"Three":[93],"these":[95],"monoamine":[98],"oxidase":[99],"inhibitors":[100],"nialamide,":[101,180],"isocarboxazid,":[102,139,181],"phenelzine":[104],"average":[106,169],"IC(50)":[107,170],"values":[108,171],"for":[109,154,202],"inhibiting":[110,155],"71,":[113],"128,":[114],"2300":[116],"nM,":[117,177],"respectively.":[118,178],"tricyclic":[120],"antidepressant":[121],"amoxapine":[122,141,183],"(IC(50)":[123,131],"=":[124,132],"388":[125],"nM)":[126],"antimalarial":[129],"mefloquine":[130],"1.2":[133],"\u00b5M)":[134],"also":[135],"had":[136,142],"Nialamide,":[138],"no":[143],"significant":[144],"against":[146],"mammalian":[148],"but":[150],"showed":[151],"potent":[152],"endogenous":[156],"cell-based":[161],"living":[164],"intact":[165],"Escherichia":[166],"coli":[167],"17,":[173],"336,":[174],"119":[176],"Thus,":[179],"potential":[185],"be":[187],"repurposed":[188],"as":[189],"therapeutics":[190],"reduce":[192],"diarrhea":[193],"associated":[194],"irinotecan":[196],"chemotherapy":[197],"warrant":[199],"further":[200],"investigation":[201],"use.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2162578613","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
